When Hong Kong office worker W.K. Chan began putting on weight as a teenager, her doctor said it was due…
Read More »biotech
Chinese biotech firm Akeso, whose cancer drug has been hailed as a breakthrough for the nation’s pharmaceutical industry, suffered a…
Read More »
A potential multibillion-dollar deal unveiled on Friday by CSPC Pharmaceutical Group is the latest in a growing number of agreements…
Read More »
Hong Kong-based venture capital firm ORI Capital plans to launch a new fund to invest in Chinese healthcare start-ups, as…
Read More »
Shares of Chinese cancer drug developer Akeso slumped on Monday despite the company receiving a second marketing approval from the…
Read More »
When the stock markets in Hong Kong and mainland China resumed trading after a long weekend on Monday, traders knew…
Read More »
Cathie Wood, the star stock picker behind Tesla’s stratospheric valuation, has doubled down on her bets, citing the convergence of…
Read More »
Licensing deals struck by Chinese biotech start-ups with overseas partners could potentially fetch billions in revenue if their drug candidates…
Read More »
For Rick Lui, a decision to take a one-year break from university in 2021 is starting to pay off. A…
Read More »
China’s biotechnology merger and acquisition (M&A) transactions have almost doubled this year, with interest perking up among investors amid a…
Read More »